ClinicalTrials.Veeva

Menu

Vital Pulp Therapy With Different Materials for Young Permanent Teeth

M

Mansoura University

Status

Not yet enrolling

Conditions

Vital Pulp Therapy

Treatments

Other: MTA
Other: calcium hydroxide
Device: Diode Laser

Study type

Interventional

Funder types

Other

Identifiers

NCT05498337
Vital pulp therapy

Details and patient eligibility

About

This study will be conducted to:

Evaluate clinically and radiographically apexogenesis in immature permanent molars using:

  1. Calcium Hydroxide.
  2. MTA.
  3. Laser.
  4. Laser combined with MTA.

Full description

Calcium Hydroxide has been the most commonly utilized pulpotomy agent for vital pulp therapy. It is the earliest medicament employed in pulpotomy that possesses the ability to stimulate tertiary dentinogenesis. This is attributed to its high alkalinity after mixing with water. Calcium hydroxide has a high pH, and its dental use relates chiefly to its ability to stimulate mineralization and also to its antibacterial property.

Biocompatibility and sealing ability are the most important properties, which account for optimal healing response in vital pulp therapy. Unlike conventional materials, MTA has low solubility and maintains its physical integrity after placement. It has several desirable characteristics in terms of biocompatibility, bioactivity, hydrophilicity, radiopacity, sealing ability and low solubility.

Diode laser in a young permanent tooth with traumatically exposed pulp has proved to be an effective technique for Pulpotomy in an immature tooth. Therefore, the use of soft-tissue diode lasers can influence the treatment outcome and should be seen as a predicable tool for vital pulp therapy.

Enrollment

100 estimated patients

Sex

All

Ages

7 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Medically free
  • Vital teeth

Exclusion criteria

  • Medically compromised
  • Chronic abscess
  • Non-vital teeth

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Examiner
Other group
Description:
Examiner
Treatment:
Device: Diode Laser
Other: MTA
Other: calcium hydroxide
Patient
No Intervention group
Description:
Patient

Trial contacts and locations

0

Loading...

Central trial contact

Nada M Abdelkader, As. lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems